OEFA - ETF AI Analysis

Top Page

O'Shares International Developed Quality Dividend ETF (OEFA)

Rating:68Neutral

Price Target:―

OEFA, the O'Shares International Developed Quality Dividend ETF, has a solid overall rating driven mainly by high-quality leaders like ASML, HSBC, and Novartis, which show strong financial performance, healthy profitability, and generally supportive technical trends. These strengths are partly offset by holdings such as Iberdrola, SAP, Atlas Copco, and Safran, where issues like high debt, potential overvaluation, weaker momentum, or profitability challenges temper the fund’s appeal. The main risk factor is that several key holdings show signs of being expensive or overbought, which could limit future upside if market conditions change.

Positive Factors

Solid Recent Performance

The ETF has shown steady gains so far this year and in recent months, indicating generally positive momentum.

Global Diversification Across Developed Markets

Holdings spread across countries like Japan, the UK, France, Switzerland, and others help reduce reliance on any single market.

Quality Large-Cap Leaders in Top Holdings

Several major companies in the top positions, such as ASML, Novartis, Roche, and Siemens, have delivered strong year-to-date performance that supports the fund’s returns.

Negative Factors

Moderate Expense Ratio

The fund’s fee is not especially low, which slightly reduces the net return investors keep over time.

Sector Concentration in Industrials

A large tilt toward industrials means the ETF could be more affected if that sector experiences a downturn.

Mixed Performance Among Top Holdings

Some sizable positions, including Nestlé, Iberdrola, and SAP, have shown weak or negative year-to-date performance, which can drag on overall results.

OEFA vs. SPDR S&P 500 ETF (SPY)

AUM44.74M

RegionDeveloped Markets

Expense Ratio0.48%

Beta0.61

IssuerALPS

Inception DateAug 19, 2015

Dividend Yield1.89%

Asset ClassEquity

Index TrackedO'Shares International Developed Quality Dividend Index - Benchmark TR Net

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume1,571

30 Day Avg. Volume2,459

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

39.80

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering49

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

OEFA Summary

O'Shares International Developed Quality Dividend ETF (OEFA) tracks the O'Shares International Developed Quality Dividend Index, focusing on large, financially strong companies in developed countries outside the U.S. It holds well-known names like Nestlé and Novartis, and invests across many sectors, including industrials, health care, and technology, with major exposure to Europe and Japan. Someone might consider this ETF for international diversification and a focus on steady dividend payers that can provide income plus potential growth. A key risk is that its value can rise or fall with global stock markets and foreign economies.

How much will it cost me?The expense ratio for the O'Shares International Developed Quality Dividend ETF (OEFA) is 0.48%, which means you’ll pay $4.80 per year for every $1,000 invested. This is slightly higher than average because the fund is actively managed to focus on high-quality, dividend-paying companies in developed markets outside the U.S.

What would affect this ETF?This ETF, focused on developed European markets and large-cap dividend-paying companies, could benefit from stable economic growth in Europe, increased demand for high-quality dividend stocks, and advancements in sectors like technology and healthcare, which are among its top holdings. However, it may face challenges from rising interest rates, which can make dividend-paying stocks less attractive, or economic uncertainty in Europe that could impact industrial and financial sectors heavily represented in the ETF. Regulatory changes or geopolitical tensions in Europe could also negatively affect its performance.

OEFA Top 10 Holdings

This ETF leans heavily on Europe’s industrial and healthcare champions, with ASML, Siemens, Roche, and Atlas Copco doing much of the heavy lifting as their shares have been rising and adding momentum to returns. Financial giant HSBC and drugmaker Novartis are also pulling their weight with steady gains. On the flip side, consumer staple Nestlé and software leader SAP are losing steam, acting as mild brakes on performance. Overall, it’s a developed-markets ex-U.S. play, tilted toward European blue chips rather than U.S. tech titans.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	5.55%	$2.49M	€454.71B	61.10%	76 Outperform
NOVN	Novartis AG	3.63%	$1.63M	CHF238.17B	31.22%	80 Outperform
HSBA	HSBC Holdings	3.47%	$1.55M	£212.73B	42.42%	80 Outperform
NESN	Nestlé SA	3.16%	$1.42M	CHF201.28B	12.20%	71 Outperform
ROG	Roche Holding AG	3.15%	$1.41M	CHF287.83B	46.49%	73 Outperform
IBE	Iberdrola	3.06%	$1.37M	€133.99B	47.44%	67 Neutral
ABB	ABB Ltd	2.97%	$1.33M	kr1.48T	36.65%	78 Outperform
SIE	Siemens	2.94%	$1.32M	€195.89B	11.12%	74 Outperform
CBA	Commonwealth Bank of Australia	2.92%	$1.31M	AU$294.57B	6.50%	64 Neutral
SAF	SAFRAN SA	2.77%	$1.24M	€136.93B	34.31%	67 Neutral

OEFA Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

33.88

Positive

100DMA

33.42

Positive

200DMA

32.80

Positive

Market Momentum

MACD

0.30

Negative

RSI

62.27

Neutral

STOCH

92.95

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For OEFA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.42, equal to the 50-day MA of 33.88, and equal to the 200-day MA of 32.80, indicating a bullish trend. The MACD of 0.30 indicates Negative momentum. The RSI at 62.27 is Neutral, neither overbought nor oversold. The STOCH value of 92.95 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OEFA.

OEFA Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
OEFA	―	―	$44.74M	0.48%	―
QLVD	―	―	$63.23M	0.12%	―
DEEF	―	―	$58.74M	0.24%	―
INEQ	―	―	$54.38M	0.45%	―
STXI	―	―	$23.50M	0.29%	―
FFDI	―	―	$15.86M	0.55%	―

Performance Comparison

OEFA

O'Shares International Developed Quality Dividend ETF

35.22

5.44

18.27%

QLVD

FlexShares Developed Markets ex-US Quality Low Volatility Index Fund

―

DEEF

Xtrackers FTSE Developed ex US Multifactor ETF

―

INEQ

Columbia International Equity Income Etf

―

STXI

Strive International Developed Markets ETF

―

FFDI

Fidelity Fundamental Developed International ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents